Two Sigma Investments, LP Harmony Biosciences Holdings, Inc. Transaction History

Two Sigma Investments, LP

$50.6 Billion
Q2 2025

A detailed history of Two Sigma Investments, LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 238,888 shares of HRMY stock, worth $8.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

238,888

Previous 345,807 30.92%

Holding current value

$8.47 Million

Previous $11.5 Million 34.23%

% of portfolio

0.01%

Previous 0.03%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$27.94 - $35.91 $2.99 Million - $3.84 Million	-106,919 Reduced 30.92%	238,888 $7.55 Million
Q1 2025 May 15, 2025	BUY	$32.18 - $40.46 $2.26 Million - $2.84 Million	70,213 Added 25.48%	345,807 $11.5 Million
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $4.22 Million - $5.5 Million	132,595 Added 92.72%	275,594 $9.48 Million
Q3 2024 Nov 14, 2024	BUY	$30.0 - $39.95 $1.49 Million - $1.98 Million	49,640 Added 53.17%	142,999 $5.71 Million
Q2 2024 Aug 14, 2024	BUY	$28.81 - $33.01 $659,057 - $755,136	22,876 Added 32.46%	93,359 $2.82 Million
Q1 2024 May 15, 2024	BUY	$29.93 - $35.06 $1.81 Million - $2.12 Million	60,479 Added 604.55%	70,483 $2.37 Million
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $2.2 Million - $3.88 Million	-114,837 Reduced 91.99%	10,004 $323,000
Q3 2023 Nov 14, 2023	SELL	$31.89 - $39.03 $7.44 Million - $9.1 Million	-233,252 Reduced 65.14%	124,841 $4.09 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $3.94 Million - $4.83 Million	129,170 Added 56.43%	358,093 $12.6 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $1.4 Million - $2.46 Million	45,577 Added 24.86%	228,923 $7.47 Million
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $2.11 Million - $2.83 Million	46,509 Added 33.99%	183,346 $10.1 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $4.28 Million - $5.65 Million	101,837 Added 290.96%	136,837 $6.06 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $6.47 Million - $10.1 Million	-193,000 Reduced 84.65%	35,000 $1.71 Million
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $7.17 Million - $11.1 Million	216,491 Added 1881.06%	228,000 $11.1 Million
Q4 2021 Feb 14, 2022	BUY	$34.09 - $43.91 $392,341 - $505,360	11,509 New	11,509 $491,000
Q1 2021 May 17, 2021	SELL	$27.56 - $40.37 $217,393 - $318,438	-7,888 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $250,365 - $404,969	7,888 New	7,888 $285,000

Others Institutions Holding HRMY

# of Institutions

285

Shares Held

46.2M

Call Options Held

279K

Put Options Held

69.9K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.1B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Harmony Biosciences Holdings, Inc. Transaction History